Close Menu


LGC is CSPro certified in Berlin and can provide sequencing services using Illumina technology.

KBioscience develops genotyping assays using a fluorescence-based competitive allele-specific PCR technique that it calls KASP.

LGC Buys KBioscience

LGC's Genomics division and KBioscience will be combined to offer genomic services and solutions.

Biosearch has denied all allegations set forth by Life Technologies in a previously filed patent-infringement lawsuit revolving around the use of fluorescence-quenched oligonucleotide probes in PCR, diagnostics, and other DNA analysis applications.

Biosearch has granted a license to IMDx for patents related to Biosearch's fluorophores and dark quencher dyes; and will manufacture cGMP oligonucleotides for IMDx for use in PCR-based human in vitro diagnostics, including those being developed in partnership with Abbott.

IMDx received access to patents covering Biosearch's BHQ, CAL Fluor, and Quasar technologies.

Life Tech claims that Biosearch is infringing one or more claims of a patent related to oligonucleotide PCR probes by manufacturing and selling its BHQplus probes for quantitative PCR applications.

The platform will be based on isothermal amplification and its developers aim to cut the amount of time it takes to diagnose STDs to 15 minutes or less at the point of care.

Biosearch has licensed from the US Centers for Disease Control and Prevention new H1N1 influenza probes and primers for more sensitive and specific H1N1 detection assays.

The firm has licensed the new signatures that it said provide enhanced sensitivity and specificity for H1N1 specimens.


The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.